GALECTIN THERAPEUTICS INC (GALT) announced Loss for second quarter of -$7.584 million
The company's earnings totaled -$7.584 million, or -$0.12 per share. This compares with -$12.435 million, or -$0.20 per share, last year.
GALECTIN THERAPEUTICS INC earnings at a glance (GAAP) :
-Earnings: -$7.584 Mln. vs. -$12.435 Mln. last year.-EPS: -$0.12 vs. -$0.20 last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.